Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
FEBS Open Bio · 2025-02 · 15 (2) · 236-253
DOI: 10.1002/2211-5463.13850 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Open Bio, online erschienen am 19.06.2024. Verfasst von Nehad S El Salamouni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Australia. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Protein Engineering. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ARC Centre of Excellence in Quantum Biotechnology, National Health and Medical Research Council (NHMRC).
Abstract (Originalsprache)
Nanobodies, the smallest functional antibody fragment derived from camelid heavy‐chain‐only antibodies, have emerged as powerful tools for diverse biomedical applications. In this comprehensive review, we discuss the structural characteristics, functional properties, and computational approaches driving the design and optimisation of synthetic nanobodies. We explore their unique antigen‐binding domains, highlighting the critical role of complementarity‐determining regions in target recognition and specificity. This review further underscores the advantages of nanobodies over conventional antibodies from a biosynthesis perspective, including their small size, stability, and solubility, which make them ideal candidates for economical antigen capture in diagnostics, therapeutics, and biosensing. We discuss the recent advancements in computational methods for nanobody modelling, epitope prediction, and affinity maturation, shedding light on their intricate antigen‐binding mechanisms and conformational dynamics. Finally, we examine a direct example of how computational design strategies were implemented for improving a nanobody‐based immunosensor, known as a Quenchbody. Through combining experimental findings and computational insights, this review elucidates the transformative impact of nanobodies in biotechnology and biomedical research, offering a roadmap for future advancements and applications in healthcare and diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Australia.
- ARC Centre of Excellence in Quantum Biotechnology, University of Wollongong, Australia.
ORCID-Profile: Nehad S El Salamouni, Haibo Yu
Förderung
- ARC Centre of Excellence in Quantum Biotechnology
- National Health and Medical Research Council (NHMRC)
Zitieren
APA
El Salamouni, N. S., Cater, J. H., Spenkelink, L. M., & Yu, H. (2025). Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. FEBS Open Bio, 15(2), 236-253. https://doi.org/10.1002/2211-5463.13850
Vancouver
El Salamouni NS, Cater JH, Spenkelink LM, Yu H. Nanobody engineering: computational modelling and design for biomedical and therapeutic applications. FEBS Open Bio. 2025;15(2):236-253. doi:10.1002/2211-5463.13850
BibTeX
@article{ElSalamouni2025,
author = {El Salamouni, Nehad S and Cater, Jordan H and Spenkelink, Lisanne M and Yu, Haibo},
title = {Nanobody engineering: computational modelling and design for biomedical and therapeutic applications},
journal = {FEBS Open Bio},
year = {2025},
volume = {15},
number = {2},
pages = {236--253},
doi = {10.1002/2211-5463.13850}
}
EUVIMED